Archives

by in
Entry Author Date Location
Myriad RBM Test Helping to Mine Secrets of Normal Immune System 04/16/14 Texas
RainDance, Angling For an IPO, Adds $16.5M From GE Ventures, Others 03/03/14 Boston
Molecular Diagnostics Are in a Rut. The Industry Needs the FDA 02/17/14 National
Myriad Genetics Acquires Crescendo Bioscience for $270M 02/04/14 San Francisco
Exact Sciences, Once Near Death, Bounces Back With Colon Cancer Test 12/18/13 Wisconsin
Q&A: Behind Ignyta’s New Strategy on Cancer Drugs and Diagnostics 12/09/13 San Diego
Foundation’s IPO Isn’t Bubbly, It’s a Jolt for Genomic Diagnostics 09/25/13 Boston
RainDance Nets $35M in Debt Financing To Continue Growth Push 09/23/13 Boston
Genomic Health Test Aims To Cut Overtreatment of Prostate Cancer 05/08/13 San Francisco
East Coast Life Sciences Roundup: Aveo, Forma, Regeneron, RainDance, & More 05/03/13 Boston
RainDance Secures $20M, and a Believer in Myriad Genetics 04/29/13 Boston
RainDance Technologies Lands $20,000,000 Series E Financing Round 04/29/13 Boston
Crescendo Bioscience Snags $28M For Arthritis Test 01/03/13 San Francisco
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Mayo and Myriad: Can Two Patent Rulings Chill Innovation? 08/07/12 National
Satori Snaps Up $15M for Alzheimer’s Drugs 02/23/12 Boston
Crescendo Bioscience Nabs $56M to Help Personalize Rheumatoid Arthritis Therapy 09/08/11 San Francisco
Crescendo Bioscience Obtains $25,000,000 New Funding Round 09/08/11 San Francisco
Metamark, Stealthy Startup with Dana-Farber Roots, Seeks to Tell Docs When to Treat Prostate Cancer, and When Not 02/24/11 Boston
Stopping Alzheimer’s Cold: Satori Raises $22M to Pursue Its Vision 01/08/09 Boston
Epix Unveiling Full Alzheimer’s Results at Medical Meeting, No More Surprises 07/22/08 Boston
Page 1 of 1